Envista EV/EBIT NVST

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2020.

Today, Oct 23, 2026: 14.9×
6-year median: 21.8×
Against its 6-year history: 12th; percentile: 0 is its lowest day, 100 its highest
6-year range: 12.5× to 148×
Peer median: 26.8×

Envista's EV/EBIT is 14.9× as of Oct 23, 2026.

That is below its 6-year median of 21.8×, lower than on 88% of days in the last 6 years.

Over that time it ranged from 12.5× in Jul 2024 to 148× in Feb 2021.

The median for 10 medical instruments and supplies stocks of a similar size is 26.8×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	14.9×	14.5×	27.0×
2025	20.8×	18.5×	36.2×
2024	29.9×	12.5×	34.1×
2023	14.9×	13.6×	24.4×
2022	20.4×	18.1×	24.5×
2021	22.2×	19.3×	148×
2020	127×	55.6×	127×

Against its peers

Companies in Medical - Instruments & Supplies nearest Envista's size, closest first, today.

Company	EV/EBIT
NVSTEnvista	14.9×
ICUIICU Medical	45.9×
BMIBadger Meter	26.2×
WRBYWarby Parker	n/m
VNTVontier	10.9×
ATRCAtriCure	208×
HAEHaemonetics	26.8×
MMSIMerit Medical Systems	28.6×
UFPTUFP Technologies	24.9×
INSPInspire Medical Systems	32.6×
MSAMSA Safety	18.0×
Peer median	26.8×

Where Envista ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Envista

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.